PatientsLikeMe ™

all
Skip over navigation
Join Now (It's free!)

Already a member? Log in

Share your real-world treatment experience
with patients just like you.
Select a community
All Communities

See More Treatments

See all treatments in the PatientsLikeMe system shared by patients just like you.


Brand Names: Stalevo, Stalevo 100, Stalevo 150, Stalevo 200, Stalevo 50
Generic Name: Carbidopa-Levodopa-Entacapone

What is Carbidopa-Levodopa-Entacapone? The combination of levodopa, carbidopa, and entacapone is used for Parkinson's Disease. Levodopa is the precursor to dopamine, carbidopa slows the breakdown of levodopa, while entacapone improves the efficacy of levodopa.

See more information, including instructions, precautions, side effects, and interactions.


Reasons Taken

228 patients in the community are taking or have taken Carbidopa-Levodopa-Entacapone.

Reason # Patients Percentage of patients
Treat Parkinson's 167 73%
Stiffness/spasticity 11 4%
Other 11 4%
Slowness 2 <1%
Support another treatment 2 <1%
Mobility 2 <1%
disease-related symptoms 2 <1%
Memory problems 1 <1%
Don't know 1 <1%
General health 1 <1%
Treat my PSP 1 <1%
Brain fog 1 <1%
Slurred speech 1 <1%

Dosages

Based on the patients currently taking Carbidopa-Levodopa-Entacapone.

Top 10 (Show all)

All (Show Top 10)

  0 mg day 0 mg none 0.05 mg day 3 mg day 3 other day 4 mg day 4 other day 6 mg day 6 other day 25 mg day 37.5 mg day 50 mg day 80 mg day 100 mg day 125 mg day 150 mg day 200 mg day 200 other day 250 mg day 300 mg day 350 mg day 400 mg day 450 mg day 500 mg day 600 mg day 700 mg day 750 mg day 800 mg day 850 mg day 900 mg day 1000 mg day 1200 mg day 1400 mg day 1600 mg day
  16 Number of Patients: 16 3 Number of Patients: 3 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 3 Number of Patients: 3 1 Number of Patients: 1 2 Number of Patients: 2 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 5 Number of Patients: 5 1 Number of Patients: 1 14 Number of Patients: 14 1 Number of Patients: 1 8 Number of Patients: 8 15 Number of Patients: 15 2 Number of Patients: 2 2 Number of Patients: 2 24 Number of Patients: 24 1 Number of Patients: 1 19 Number of Patients: 19 8 Number of Patients: 8 7 Number of Patients: 7 21 Number of Patients: 21 2 Number of Patients: 2 4 Number of Patients: 4 11 Number of Patients: 11 1 Number of Patients: 1 3 Number of Patients: 3 6 Number of Patients: 6 4 Number of Patients: 4 1 Number of Patients: 1 1 Number of Patients: 1  

Duration

How long current patients have been taking Carbidopa-Levodopa-Entacapone or how long patients were taking Carbidopa-Levodopa-Entacapone before stopping.

Currently taking Carbidopa-Levodopa-Entacapone

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
7
7
21
21
20
52

Stopped taking Carbidopa-Levodopa-Entacapone

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
3
7
7
11
4
6
Why Patients Stopped Taking Carbidopa-Levodopa-Entacapone (multiple reasons could be selected)
Reason # Patients Percentage of patients
Side effects too severe 18 47% Side effects too severe: 47%
Doctor's advice 8 21% Doctor's advice: 21%
Did not seem to work 7 18% Did not seem to work: 18%
Expense 5 13% Expense: 13%
Other 5 13% Other: 13%
Not indicated 4 11% Not indicated: 11%
Personal research 1 3% Personal research: 3%

Patient Reported Evaluations

Results from 22 patient evaluations. See the overall results and all individual evaluations.

Efficacy (Effect based on reason taken)

Major 70% 14
Moderate 20% 4
Can't tell 10% 2

Treat Parkinson's

Side-effects (as an overall problem)

Severe 5% 1
Moderate 14% 3
Mild 41% 9
None 41% 9

Top reported side-effects include: legs cramping when wearing off, Slight nausea, tremors increase when wearing off

Summary results are based on 22 individual responses. For more information, see overall results for Adherence, Burden and Cost.

Individual Patient Reported Evaluations (2 of 22)

  • EfficacyMajor
  • Side-effectsMild
  • Treat Parkinson's

  • TomBerdine
    Mouth/throat: moderate
    Arms: moderate
    Chest: none
    Legs: mild
    See profile
  • TomBerdine
  • by TomBerdine
    Aug 20, 2008
  • EfficacyMajor
  • Side-effectsNone
  • Treat Parkinson's
Advice/Tips
Longer lasting then the PARCOPA but much slower to take effect. About 45minutres to an hour. But last up to 3hours where the PARCOPA lasts only an hour or a little more.

See all evaluation results for Carbidopa-Levodopa-Entacapone



Back to top